← Back to headlines
Edesa Biotech Reaffirms 2026 Timeline for Vitiligo Treatment Study
Edesa Biotech (EDSA) has reaffirmed its previously announced timeline for a clinical study on a vitiligo treatment, expected to commence in 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
Ben-Gurion University Study Links Walking Speed to Longevity in Older Adults
26m ago
Tel Aviv University Study Reveals Mechanism of Cancer Growth and Spread
3h ago